Researchers have done path breaking research, which can help people suffering from diabetes to postpone or decrease their need for insulin injections.
Michel Pairet, head of pharmaceutical company Boehringer Ingelheim’s non-clinical research and development, said this treatment could be a cure if it is linked with early diagnosis and treatment.
Early trials have shown promising results in strengthening the beta cells in the pancreas, which secrete insulin to control high levels of glucose in the blood, the Daily Express reported.
Stem cells are used to protect and regenerate beta cells, which normally are damaged by high sugar diets in the process.
Pairet said that the next wave of innovation is to try to protect the beta cell in the pancreas and maybe to cure diabetes by inducing the regeneration of the beta cells.
He said that during diabetes, the beta cells disappear because of inflammatory mechanisms, however, not all mechanisms are known yet.
Pairet explained that you can protect the beta cells or you can identify factors for the regeneration of the cells based on progenitor cells and try to help these cells regenerate, meaning that the treatment could help stop or delay the disease and its complications.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
Please Email the Editor